Fund shareholders of CELLECTAR BIOSCIENCES INC
ISIN US15117F8804 · United States · LEI 5493000NFZCRG7BYQV93
- Fund shareholders
- 8
- Of which ETFs
- 0 8 other funds
- Value held
- ≈ 353.4K $ 300.1K $ · 45.4K €
- Share of capital
- 1.2 % of 9.5M shares on Aug 11, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 50,770 | 129K $ | 0.54 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 31,114 | 79K $ | 0.00 % | 0.33 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 21,235 | 69.4K $ | 0.00 % | 0.22 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 4,664 | 15.3K $ | 0.05 % | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 2,064 | 6.7K $ | 0.02 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 200 | 654 $ | 0.00 % | as of Feb 28, 2026 ↗ | |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1 | 2.5 $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. | 45.4K € | 0.24 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. | 0.24 % | as of Dec 31, 2025 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 7 | -1 | 110,048 | +9.6 % |
| 2026Q1 | 8 | -1 | 100,425 | +43.1 % |
| 2025Q4 | 9 | +4 | 70,200 | +16.3 % |
| 2025Q3 | 5 | 60,381 |
Institutional managers
16 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Bleichroeder LP | 100,000 | 254K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 52,778 | 134.1K $ | as of Mar 31, 2026 |
| Sequoia Financial Advisors, LLC | 18,850 | 47.9K $ | as of Mar 31, 2026 |
| Warberg Asset Management LLC | 13,900 | 35.3K $ | as of Mar 31, 2026 |
| Riverview Capital Advisers, LLC | 10,384 | 50.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 9,647 | 24.5K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,745 | 12.1K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 793 | 2K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 510 | 1.3K $ | as of Mar 31, 2026 |
| TD Waterhouse Canada Inc. | 63 | 154 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 11 | 28 $ | as of Mar 31, 2026 |
| FMR LLC | 10 | 25 $ | as of Mar 31, 2026 |
| JONES FINANCIAL COMPANIES LLLP | 3 | 8 $ | as of Mar 31, 2026 |
| US BANCORP \DE\ | 3 | 8 $ | as of Mar 31, 2026 |
| DANSKE BANK A/S | 2 | 5 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 1 | 2 $ | as of Mar 31, 2026 |
Declared shareholders of CELLECTAR BIOSCIENCES INC
2 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 9.99 % | 798,382 | as of May 29, 2026 · SCHEDULE 13G |
| Stonepine Capital Management, LLC and 3 others | 9.90 % | 863,277 | as of May 4, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of CELLECTAR BIOSCIENCES INC". https://titelia.com/en/stocks/cellectar-biosciences-inc-US15117F8804